Colorectal cancer (CRC) is one of the most common cancers in the world, having both high
prevalence and mortality. It is usually diagnosed at advanced stages due to the limitations of …

CEMIP (cell migration‐inducing protein), also known as KIAA1199 or HYBID, is a protein
involved in the depolymerisation of hyaluronic acid (HA), a major glycosaminoglycan …

BACKGROUND Epi proColon® is a new blood-based colorectal cancer (CRC) screening
test designed to determine the methylation status of a promoter region of the SEPT9 (septin …

Background The development of colorectal cancer (CRC) is accompanied by extensive
epigenetic changes, including frequent regional hypermethylation particularly of gene …

KIAA1199, also known as CEMIP or HYBID, is an important member of the Human
Unidentified Gene-Encoded (HUGE) database. Accumulated evidence has revealed that …

Background Specific genes are methylated with high frequency in colorectal neoplasia, and
may leak into blood. Detection of multiple methylated DNA biomarkers in blood may improve …

Simple Summary CEMIP (cell migration-inducing and hyaluronan-binding protein) has been
implicated in the pathogenesis of numerous diseases, including colorectal and other forms …

Colorectal cancer (CRC) is a slow-developing cancer (10–15 years) with one of the highest
frequencies in the world's population. Many countries have implemented various CRC …

Abstract Carbohydrate antigen (CA) 19-9 is the only diagnostic marker used in pancreatic
cancer despite its limitations. Here, we aimed to identify the diagnostic role of CEMIP (also …

Background To determine the metabolic characteristics of patients with colon cancer (CC)
and rectal cancer (RC) using gas chromatography‐mass spectrometry (GC‐MS)‐based …